Procter & Gamble Hygiene and Health Care Ltd News

P&G Hygiene net profit rises marginally to Rs 212 crore in Sep quarter

Procter & Gamble Hygiene and Health Care Ltd on Wednesday reported a marginal 0.57 per cent rise in profit after tax at Rs 211.90 crore for the first quarter ended September 2024. The company, which follows the July-June financial year, had reported a profit after tax of Rs 210.69 crore in the corresponding quarter of the previous fiscal. Its revenue from operations of Procter & Gamble Hygiene and Health Care Ltd (PGHH) marginally fell by 0.28 per cent to Rs 1,135.16 crore during the quarter under review. It was Rs 1,138.35 crore a year ago. "The volume growth in the industry continues to be muted. The company witnessed growth in the feminine care category and continued to make progress on improving the structural profitability of the business in the quarter," said an earnings statement from PGHH. PGHH's total expense, which operates in the healthcare and feminine care segment with brands Vicks and Whisper in its portfolio, declined 1.3 per cent to Rs 858.29 crore in the ...

P&G investing in quick commerce as convenience drives consumption

India emerging as destination with most evolved supply chain know-how, says CEO

Best option is to double down on market strategy, says P&G India

On the PGHH call, Mrinalini Srinivasan, CFO, said that positive trends are finally emerging in the Indian fast-moving consumer goods (FMCG) industry, both in urban and rural areas

P&G Hygiene and Health down 4% on weak June qtr; Rs 95-dividend announced

The fall in Procter & Gamble Hygiene and Health stock came after the company announced a weak set of financial results for the fiscal and quarter ended June 30, 2024.

P&G Q4 results: Profit after tax down 46% at Rs 81 cr on high spending

Procter & Gamble Hygiene and Health Care Ltd (PGHH) on Wednesday reported 46.40 per cent decline in profit after tax at Rs 81.06 crore for June quarter 2024 on account of increased spending. The company, which follows July-June financial year, had reported a profit after tax of Rs 151.24 crore in the corresponding quarter of the previous fiscal. However, PGHH's revenue from operations was at 931.75 crore as against Rs 852.53 crore a year ago. "PAT for the quarter was Rs 81 crore, with an increase in spending for demand generation to support innovation in healthcare and feminine care," said an earning statement from PGHH. Total expense was at Rs 826.78 crore, up 26 per cent year-on-year. Total income of the Proctor & Gamble entity, which has a portfolio of Vicks in healthcare and Whisper in feminine care, was up 8.86 per cent to Rs 939.06 crore. For the full year, PGHH's profit after tax was flat at Rs 675.02 crore as against Rs 678.14 crore in the previous year. "Reported PAT .

P&G Health stock slips 4% on weak Q4 performance; Rs 60 dividend announced

The drop in the stock price of Procter & Gamble Health came after the company announced a weak set of June quarter results (Q4FY24).